Clinical Trials

Showing trials with last updates posted in 2021.

NCT01886378 | COMPLETED | PHASE2
29 participants

A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

Study Type:
INTERVENTIONAL
Last Updated:
2021-02-11
Start Date:
2014-02-06
Completion:
2016-08-25
Conditions
  • Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
  • Carnitine Palmitoyltransferase (CPT II) Deficiency
  • Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
  • Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency
  • Trifunctional Protein (TFP) Deficiency
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page